Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation

Journal:

Nature Communications

Published:

2025-08-09

DOI:

10.1038/s41467-025-62634-9

Affiliations:

3

Authors:

9

Go to article

Institutions	Authors	Share
State Key Laboratory of Anti-Infective Drug Discovery and Development, China	8.000000	0.89
Hong Kong University of Science and Technology (Guangzhou), China	0.500000	0.06
The Chinese University of Hong Kong (CUHK), China	0.500000	0.06

Interested in Industrial Biotechnology?